Detalhe da pesquisa
1.
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.
Annu Rev Pharmacol Toxicol
; 60: 333-352, 2020 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31337270
2.
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent Clostridioides difficile during COVID-19.
Anaerobe
; 80: 102699, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702174
3.
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
JAMA
; 329(14): 1170-1182, 2023 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039791
4.
Medication history-wide association studies for pharmacovigilance of pregnant patients.
Commun Med (Lond)
; 2: 115, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124058
5.
Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases.
Front Genet
; 12: 707836, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34394194
6.
Machine learning on drug-specific data to predict small molecule teratogenicity.
Reprod Toxicol
; 95: 148-158, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32428651
7.
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study.
Mol Cancer Ther
; 19(12): 2454-2464, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33033174
8.
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity.
Bioorg Med Chem Lett
; 19(8): 2240-3, 2009 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19299128
9.
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity.
Bioorg Med Chem Lett
; 19(7): 1916-20, 2009 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19268584
10.
Systematically Prioritizing Candidates in Genome-Based Drug Repurposing.
Assay Drug Dev Technol
; 17(8): 352-363, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769998
11.
Phospholipase D: enzymology, functionality, and chemical modulation.
Chem Rev
; 111(10): 6064-119, 2011 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21936578
12.
Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.
Target Oncol
; 13(1): 61-68, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218624
13.
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.
Assay Drug Dev Technol
; 15(8): 354-361, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29193979
14.
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
Assay Drug Dev Technol
; 15(3): 113-119, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379727
15.
EHRs could clarify drug safety in pregnant people.
Nat Med
; 26(6): 820-821, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32457445
16.
Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymes.
ACS Chem Biol
; 10(2): 421-32, 2015 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25384256
17.
The ethical mouse: be not like Icarus.
Am J Bioeth
; 7(5): 57-8, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17497509
18.
Ethical considerations in the communication of unexpected information with clinical implications.
Am J Bioeth
; 6(6): 46-8; author reply W10-2, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17085410
19.
Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor.
J Med Chem
; 53(18): 6706-19, 2010 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20735042